...
search icon
  • Apple, Inc AAPL
  • S&P 500 ETF Trust SPDR SPY
  • Alphabet Inc. - Class A Shares GOOGL
  • Microsoft Corporation MSFT
  • Meta Platforms Inc META
  • Netflix, Inc. NFLX
  • Amazon.com Inc. AMZN
  • Spotify Technology SA SPOT
    bold-img

    Boundless Bio, Inc. Common Stock, Common Stock

    BOLD

    NSQ

    $1.54

    -$0.02

    (-1.28%)

    1D
    Industry: Biotechnology Sector: Health Care

    Analyst Forecast

    Overview Returns Financials Ratios News FAQs

    Price Chart

    Key Metrics

    Market Cap info-icon
    This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
     $37.83M
    P/E Ratio info-icon
    This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
     0.1997
    Volume info-icon
    This is the total number of shares traded during the most recent trading day.
     0
    Avg Volume info-icon
    This is the average number of shares traded during the most recent 30 days.
     0
    Dividend Yield info-icon
    This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
     0.00%
    Beta info-icon
    This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
     0
    52-week Range info-icon
    This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
    $1.06 L
    $11.87 H
    $1.54

    About Boundless Bio, Inc. Common Stock, Common Stock

    Boundless Bio, Inc., a clinical-stage oncology company, develops cancer therapeutics to address the unmet need of patients with oncogene amplified tumors by interrogating extrachromosomal DNA (ecDNA). The company's lead product candidate is BBI-355, an ecDNA-directed therapeutic candidate and oral inhibitor of checkpoint kinase 1 that is in Phase 1/2 clinical trial in patients with oncogene amplified cancers. It also develops BBI-098, a picomolar biochemical inhibition of checkpoint kinase 1 demonstrating central nervous system penetrance in preclinical models. In addition, the company offers ECHO, an ecDNA harboring oncogenes diagnostic test to detect ecDNA in patient tumor specimens; and Spyglass platform, a platform used to identify druggable targets in oncogene amplified cancers. The company was formerly known as Pretzel Therapeutics, Inc. and changed its name to Boundless Bio, Inc. in July 2019. Boundless Bio, Inc. was incorporated in 2018 and is headquartered in San Diego, California. more

    Industry: BiotechnologySector: Health Care

    Returns

    Time FrameBOLDSectorS&P500
    1-Week Return-6.67%-2.07%-2.54%
    1-Month Return-2.53%-3.97%8.2%
    3-Month Return-20.21%-11.71%-3.05%
    6-Month Return-39.84%-10.35%-3.06%
    1-Year Return-85.36%-10.05%10.13%
    3-Year Return-89.19%-0.44%45.94%

    Financials

    Dec '18Dec '21Dec '22Dec '23Dec '245YR TREND
    Total Revenue-----[{"date":"2018-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
    Cost of Revenue-682.00K942.00K957.00K1.09M[{"date":"2018-12-31","value":"-","profit":true},{"date":"2021-12-31","value":62.8,"profit":true},{"date":"2022-12-31","value":86.74,"profit":true},{"date":"2023-12-31","value":88.12,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
    Gross Profit-(682.00K)(942.00K)(957.00K)-[{"date":"2018-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-68200000,"profit":false},{"date":"2022-12-31","value":-94200000,"profit":false},{"date":"2023-12-31","value":-95700000,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
    Gross Margin-----[{"date":"2018-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
    Operating Expenses134.37M25.30M46.47M54.80M73.27M[{"date":"2018-12-31","value":100,"profit":true},{"date":"2021-12-31","value":18.83,"profit":true},{"date":"2022-12-31","value":34.58,"profit":true},{"date":"2023-12-31","value":40.78,"profit":true},{"date":"2024-12-31","value":54.53,"profit":true}]
    Operating Income(134.37M)(25.30M)(46.47M)(54.80M)(73.27M)[{"date":"2018-12-31","value":-13437200000,"profit":false},{"date":"2021-12-31","value":-2530100000,"profit":false},{"date":"2022-12-31","value":-4646900000,"profit":false},{"date":"2023-12-31","value":-5479600000,"profit":false},{"date":"2024-12-31","value":-7326700000,"profit":false}]
    Total Non-Operating Income/Expense-187.00K1.24M10.64M15.80M[{"date":"2018-12-31","value":"-","profit":true},{"date":"2021-12-31","value":1.18,"profit":true},{"date":"2022-12-31","value":7.82,"profit":true},{"date":"2023-12-31","value":67.38,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
    Pre-Tax Income(128.82M)(25.21M)(45.90M)(49.43M)(65.36M)[{"date":"2018-12-31","value":-12882100000,"profit":false},{"date":"2021-12-31","value":-2521000000,"profit":false},{"date":"2022-12-31","value":-4590100000,"profit":false},{"date":"2023-12-31","value":-4943400000,"profit":false},{"date":"2024-12-31","value":-6536300000,"profit":false}]
    Income Taxes5.55M(96.00K)(668.00K)(5.28M)(65.36M)[{"date":"2018-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-1.73,"profit":false},{"date":"2022-12-31","value":-12.03,"profit":false},{"date":"2023-12-31","value":-95.15,"profit":false},{"date":"2024-12-31","value":-1177.5,"profit":false}]
    Income After Taxes-(25.11M)(45.23M)(44.15M)-[{"date":"2018-12-31","value":"-","profit":true},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
    Income From Continuous Operations-(25.21M)(45.90M)(49.43M)(65.36M)[{"date":"2018-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-2521000000,"profit":false},{"date":"2022-12-31","value":-4590100000,"profit":false},{"date":"2023-12-31","value":-4943400000,"profit":false},{"date":"2024-12-31","value":-6536300000,"profit":false}]
    Income From Discontinued Operations-----[{"date":"2018-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
    Net Income(128.82M)(25.21M)(45.90M)(49.43M)(65.36M)[{"date":"2018-12-31","value":-12882100000,"profit":false},{"date":"2021-12-31","value":-2521000000,"profit":false},{"date":"2022-12-31","value":-4590100000,"profit":false},{"date":"2023-12-31","value":-4943400000,"profit":false},{"date":"2024-12-31","value":-6536300000,"profit":false}]
    EPS (Diluted)(3.40)---(17.66)[{"date":"2018-12-31","value":-340,"profit":false},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":-1766,"profit":false}]

    Ratios

    Liquidity

    These ratios help you determine the liquidity of the company. Higher is better.

    BOLD
    Cash Ratio 21.81
    Current Ratio 22.15

    Asset Efficiency

    These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

    BOLD
    ROA (LTM) -29.89%
    ROE (LTM) -54.06%

    Liabilities

    These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

    BOLD
    Debt Ratio Lower is generally better. Negative is bad. 0.29
    Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.71

    Valuation

    These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

    BOLD
    Trailing PE 0.20
    Forward PE NM
    P/S (TTM) 0.00
    P/B 0.25
    Price/FCF NM
    EV/R 0.00
    EV/Ebitda NM

    Discover more

    Tsla

    Tesla, Inc.
    aaple

    Apple, Inc.
    GOOGL

    Alphabet Inc. - Class A Shares
    META

    Meta Platforms Inc
    AMZN

    Amazon.com Inc.
    Microsoft

    Microsoft Corporation
    NVDA

    NVIDIA Corporation
    BRK

    Berkshire Hathaway Inc. Hld B
    LLY

    Eli Lilly and Company

    FAQs

    What is Boundless Bio, Inc. Common Stock share price today?

    Boundless Bio, Inc. Common Stock (BOLD) share price today is $1.54

    Can Indians buy Boundless Bio, Inc. Common Stock shares?

    Yes, Indians can buy shares of Boundless Bio, Inc. Common Stock (BOLD) on Vested. To buy Boundless Bio, Inc. Common Stock from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in BOLD stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

    Can Fractional shares of Boundless Bio, Inc. Common Stock be purchased?

    Yes, you can purchase fractional shares of Boundless Bio, Inc. Common Stock (BOLD) via the Vested app. You can start investing in Boundless Bio, Inc. Common Stock (BOLD) with a minimum investment of $1.

    How to invest in Boundless Bio, Inc. Common Stock shares from India?

    You can invest in shares of Boundless Bio, Inc. Common Stock (BOLD) via Vested in three simple steps:

    • Click on Sign Up or Invest in BOLD stock at the top of this page
    • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
    • Transfer USD funds to your US Brokerage account and start investing in Boundless Bio, Inc. Common Stock shares
    What is Boundless Bio, Inc. Common Stock 52-week high and low stock price?

    The 52-week high price of Boundless Bio, Inc. Common Stock (BOLD) is $11.87. The 52-week low price of Boundless Bio, Inc. Common Stock (BOLD) is $1.06.

    What is Boundless Bio, Inc. Common Stock price-to-earnings (P/E) ratio?

    The price-to-earnings (P/E) ratio of Boundless Bio, Inc. Common Stock (BOLD) is 0.1997

    What is Boundless Bio, Inc. Common Stock price-to-book (P/B) ratio?

    The price-to-book (P/B) ratio of Boundless Bio, Inc. Common Stock (BOLD) is 0.25

    What is the Market Cap of Boundless Bio, Inc. Common Stock?

    The market capitalization of Boundless Bio, Inc. Common Stock (BOLD) is $37.83M

    What is Boundless Bio, Inc. Common Stock’s stock symbol?

    The stock symbol (or ticker) of Boundless Bio, Inc. Common Stock is BOLD

    Feedback

    Signup to access all features and start your US investing journey!

    • Open your account in minutes
    • Take your portfolio global, starting at just $1
    Get started

    Add ticker to compare

    Scroll to Top